GLB-333

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGLB-333
Drug Alias Nameinterleukin inhibitor (National Pharmaceuticals)GLB-333
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytokine receptors antagonistsInterleukins inhibitors
TargetsCytokine receptorsInterleukins
Therapy Area/IndicationsRejection of organ transplantationWounds and InjuriesPain +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlobe Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlobe Laboratories IncNational Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationWounds and InjuriesPain +[4] 

Other Information

ATC CodeN/A
Related LinksN/A